Showing results (31-40 of 46) with videos related to
Sort By:
Pageof 5
The Laryngoscope|August 4, 2025
Factors Influencing the Delay in Head and Neck Cancer Diagnosis in LebanonNader G Zalaquett, Jad Hosri, Zachary Elwell, et al.Annals of Intensive Care|November 19, 2025
End-tidal carbon dioxide changes induced by passive leg raising can predict fluid responsiveness in patients on veno-arterial extracorporeal membrane oxygenation: a prospective, interventional studyTimothée Hannequin, Aurore Ughetto, Jacob Eliet, et al.Journal of Voice : Official Journal of the Voice Foundation|March 21, 2025
Impact of Upper Airway Narrowing on Patient Tolerance in Office-Based Blue Laser SurgeryAbdul-Latif Hamdan, Marc Mourad, Patrick Abou Raji Feghali, et al.Journal of Voice : Official Journal of the Voice Foundation|March 10, 2026
Correlation between Obesity and Patient Tolerance to Office-Based Trans-Nasal Laryngeal ProceduresAbdul-Latif Hamdan, Lana Ghzayel, Patrick Abou Raji Feghali, et al.The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|February 17, 2024
Early temporary mechanical circulatory support for cardiogenic shock: Real-life data from a regional cardiac assistance networkAurore Ughetto, Jacob Eliet, Nicolas Nagot, et al.Journal of Voice : Official Journal of the Voice Foundation|July 7, 2026
Self-Perceived Hoarseness and Voice Disorders in E-cigarette and Conventional Cigarette UsersAbdul-Latif Hamdan, Elie Alam, Marc Mourad, et al.Expert Review of Cardiovascular Therapy|October 5, 2018
Management of advanced heart failure: a reviewEran Kalmanovich, Yohan Audurier, Mariama Akodad, et al.Journal of Clinical Medicine|May 28, 2022
Simplified TAVR Procedure: How Far Is It Possible to Go?Florence Leclercq, Pierre Alain Meunier, Thomas Gandet, et al.Thyroid Research|July 31, 2025
Thyroid angiosarcoma: a rare malignancy - case report and systematic review of the literatureSahar Taleb, Anthony Abou Mrad, Mustafa Natout, et al.Future Science OA|April 5, 2021
Idarucizumab (Praxbind®) for dabigatran reversal in patients undergoing heart transplantation: a cohort of ten patientsEran Kalmanovich, Pascal Battistella, Philippe Rouviere, et al.Pageof 5